EUVIMEDEUVIMED entdecken
Crossref

Prevalence and Incidence of Hepatitis E Infection in China

Sailimai Man, Jingzhu Fu, Xiaochen Yang, Yuan Ma, Heling Bao, Jing Du, Canqing Yu, Jun Lv, Hui Liu, Gang Li, Liming Li, Bo Wang

Clinical Gastroenterology and Hepatology · 2025

DOI: 10.1016/j.cgh.2024.07.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Sailimai Man und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China; Department of Evidence-based Medicine and B…. Hauptthemen laut MEDLINE: Hepatitis E, Hepatitis Antibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: China is an endemic area for hepatitis E virus (HEV) infection. Estimating the prevalence and incidence of HEV infection in China plays a pivotal role in informing public health policies to prevent and control hepatitis E. This study aimed to investigate the prevalence of anti-HEV IgG and incidence of HEV seroconversion in China. METHODS: This study was based on the Meinian health check-up database in China. Participants who underwent testing for anti-HEV IgG at check-up centers in 24 provinces between 2017 and 2022 were included. In the cross-sectional analyses, overall prevalence and stratified prevalence in subpopulations with various characteristics were estimated and standardized according to the 2020 census of the Chinese population. In the longitudinal analyses, the occurrence of anti-HEV IgG positivity during the follow-up was defined as an incident HEV seroconversion. Overall and stratified incidence rates were estimated and expressed as per 100 person-years. Poisson regression was used to explore risk factors associated with HEV seroconversion. RESULTS: A total of 85,238 and 11,154 participants were included in the cross-sectional and longitudinal analyses, respectively. The prevalence of anti-HEV IgG in the general population was 18.02%. During a median follow-up of 1.2 years, the incidence rate of HEV seroconversion was 1.79 per 100 person-years. Age ≥60 years, low socioeconomic status, living in coastal areas, living in areas with high drainage density, and living in areas with high anti-HEV IgG prevalence were independent risk factors for HEV seroconversion. CONCLUSIONS: Our findings would help inform policymaking for hepatitis E prevention and control in China as well as in other endemic regions of the world.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis EHepatitis AntibodiesHumansChinaMaleFemaleIncidenceMiddle AgedCross-Sectional StudiesPrevalenceAdultImmunoglobulin GHepatitis E virusYoung AdultAgedLongitudinal StudiesRisk FactorsSeroconversionAdolescentSeroepidemiologic Studies

Stichwörter der Autor:innen

EpidemiologyHepatitis EInfectious DiseaseViral Hepatitis

Substanzen

Immunoglobulin GHepatitis Antibodies

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China; Department of Evidence-based Medicine and Biostatistics, Meinian Institute of Health, Beijing, China; Meinian Pub…
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
  • Department of Evidence-based Medicine and Biostatistics, Meinian Institute of Health, Beijing, China; Department of Social Medicine and Health Education, School of Public Health, Peking University, Beijing, China.
  • Department of Evidence-based Medicine and Biostatistics, Meinian Institute of Health, Beijing, China; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College…
  • Institute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Institute of Information and Statistics, Beijing Center for Disease Prevention and Control, Beijing, China.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Man, S., Fu, J., Yang, X., Ma, Y., Bao, H., Du, J., Yu, C., Lv, J., Liu, H., Li, G., Li, L., & Wang, B. (2025). Prevalence and Incidence of Hepatitis E Infection in China. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.07.026

Vancouver

Man S, Fu J, Yang X, Ma Y, Bao H, Du J, et al. Prevalence and Incidence of Hepatitis E Infection in China. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2024.07.026

BibTeX
@article{Man2025,
  author = {Man, Sailimai and Fu, Jingzhu and Yang, Xiaochen and Ma, Yuan and Bao, Heling and Du, Jing and Yu, Canqing and Lv, Jun and Liu, Hui and Li, Gang and Li, Liming and Wang, Bo},
  title = {Prevalence and Incidence of Hepatitis E Infection in China},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1016/j.cgh.2024.07.026}
}
Kostenlos starten →